Escolar Documentos
Profissional Documentos
Cultura Documentos
Received May 1, 2012; Revised May 23, 2012; Accepted May 28, 2012
ABSTRACT
Cytoplasmic
polyadenylation
element-binding
protein (CPEB)3 is a nucleocytoplasm-shuttling
RNA-binding protein and predominantly resides in
the cytoplasm where it represses target RNA translation. When translocated into the nucleus, CPEB3
binds to Stat5b and downregulates Stat5b-dependent transcription. In neurons, the activation of
N-methyl-D-aspartate receptors (NMDARs) accumulates CPEB3 in the nucleus and redistributes CPEB3
in the nucleocytoplasmic compartments to control
gene expression. Nonetheless, it is unclear which
karyopherin drives the nuclear import of CPEB3
and which transport direction is most affected by
NMDA stimulation to increase the nuclear pool of
CPEB3. Here, we have identified that the karyopherins, IPO5 and CRM1, facilitate CPEB3 translocation by binding to RRM1 and a leucine-containing
motif of CPEB3, respectively. NMDAR signaling increases RanBP1 expression and reduces the level of
cytoplasmic GTP-bound Ran. These changes
enhance CPEB3IPO5 interaction, which consequently accelerates the nuclear import of CPEB3.
This study uncovers a novel NMDA-regulated
import pathway to facilitate the nuclear translocation of CPEB3.
INTRODUCTION
Long-term memory involves the activity-induced synthesis
of plasticity-related proteins in neurons to support
long-lasting morphological and functional changes of
synapses. This type of activity-driven gene expression is
regulated at both transcriptional and translational levels
(13). Previous research has shown that proteins enriched
at or near neuronal synapses accumulate in the nucleus in
response to stimulation. These proteins include factors
*To whom correspondence should be addressed. Tel: +886 22652 3523; Fax: +886 22785 8594; Email: yishuian@ibms.sinica.edu.tw
The Author(s) 2012. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Downloaded from http://nar.oxfordjournals.org/ at Library of Research Reactor Institute, Kyoto University on July 28, 2013
Institute of Biomedical Sciences, Academia Sinica, Taipei 11529, Taiwan, 2Graduate Institute of Microbiology,
National Taiwan University, Taipei 10051, Taiwan and 3National RNAi Core Facility, Academia Sinica, Taipei
11529, Taiwan
Downloaded from http://nar.oxfordjournals.org/ at Library of Research Reactor Institute, Kyoto University on July 28, 2013
Co-immunoprecipitation
To examine CPEB3IPO5Ran association in neurons,
8 106 cortical neurons of DIV 16 were treated with
3 min of 50 mM NMDA and then incubated for the
designated time prior to 4% formaldehyde crosslinking
at room temperature for 5 min. The xed neurons were
lysed in 1.5 ml buffer (10 mM Hepes, pH 7.5, 320 mM
sucrose, 5 mM EDTA, 5 mM DTT, 10 mM MG132, 1%
TritonX-100, 0.5% sodium deoxychlorate, 0.1% SDS, 1
protease and phosphatase inhibitors (Roche)) at 4 C for
60 min, followed by sonication for 10 s and then centrifugation at 13 000 rpm for 30 min. The supernatant was
divided, diluted with one volume of H2O, incubated with
30 ml protein G beads bound with 5 mg of CPEB3 or IPO5
Downloaded from http://nar.oxfordjournals.org/ at Library of Research Reactor Institute, Kyoto University on July 28, 2013
Downloaded from http://nar.oxfordjournals.org/ at Library of Research Reactor Institute, Kyoto University on July 28, 2013
L349ENSL353
myc-
RRM2
CPEB3
LMB -
wt (1-684)
mut2 (71-684)
mut3 (134-684)
mut4 (216-684)
mut5 (318-684)
mutN (1-427)
mutC (426-684)
mut6 (318-425)
mut7 (427-533)
mut8 (1-533)
A349A353
**
Western blot
C
C
C
C
C
C
N
N
C
C
N
+
N
N
N
N
N
N
N
N
C/N
N
N
UV-Xlinking/ SDS-PAGE
kDa
130
100
70
55
32P
mut8
mut7
mut6
mutC
+ leptomycin B (LMB)
E
mutN
signal
+ leptomycin B (LMB)
% nuclear signal
mut5
mut4
mut3
mut2
wt
myc
A349A353
35
80
P <0.0001
P <0.0001
P =0.34
mut8
+
98
97
mut6
+
87
99
003
P =0.003
40
LMB
cell#
0
90
wt
+
86
mut7
+
85
79
Figure 1. Identication of the cis-elements required for nucleocytoplasmic translocation of CPEB3. (A) Salient features of CPEB3, showing the
N-terminal glutamine-rich region (Q) and the C-terminal RNA-binding domain (RBD) composed of two RNA recognition motifs (RRM) and zinc
ngers (Zif). The LENSL motif is the nuclear export sequence. The various myc-tagged CPEB3 mutants are illustrated. The 293 T lysates containing
wild-type (wt) and mutant (mut) CPEB3 were (B) used for western blotting or (C) crosslinked with radiolabelled RNA probe for RNA-binding assay.
(D) HeLa cells expressing wt and mut CPEB3 were treated with 10 ng/ml LMB for 30 min prior to xation and immunostaining with myc
antibody. Subcellular localizations of wt and mut CPEB3 proteins in LMB-treated cells are summarized in (A), N: nucleus; C: cytoplasm.
Scale: 20 mm (E) To quantify nuclear distribution of mut6, mut7, mut 8 and wt CPEB3, 80100 transfected cells LMB treatment were
analysed using MetaMorph software. The nuclear CPEB3 signal was divided by total cellular signal to yield the % nuclear signal. Error bars
indicate SD. Statistical analysis was performed using Students t-test.
Downloaded from http://nar.oxfordjournals.org/ at Library of Research Reactor Institute, Kyoto University on July 28, 2013
zif
myc-CPEB3-wt
y
myc-CPEB3-wt
y
MAP2
myc-CPEB3-mut7 myc-CPEB3-mut7
MAP2
myc-CPEB3-mut6
y
myc-CPEB3-mut6
y
% of neurons
+NMDA 30
0
-NMDA 30
cytoplasm (C>N)
nucleus (N>=C)
100
80
60
40
20
0
NMDA
cell #
wt
+
80 79
mut6
+
52 57
mut7
- +
59 71
Figure 2. Deletion of NLS in CPEB3 affects its nuclear accumulation in NMDA-treated neurons. (A) Neurons infected with lentivirus expressing
myc-tagged wt, mut6 or mut7 CPEB3 were stimulated with or without 50 mM NMDA for 30 min before immunostaining with myc and MAP2
antibodies. Scale: 20 mm. (B) The localization of CPEB3 wt, mut6 and mut7 in neurons was analysed. A staining signal in the cytoplasm exceeding
that in the nucleus is considered as cytoplasm-localized (light grey bar), and the rest is grouped as nucleus-localized (dark grey bar).
Downloaded from http://nar.oxfordjournals.org/ at Library of Research Reactor Institute, Kyoto University on July 28, 2013
NMDA 30
+N
NMDA 30
+N
-NMDA 30
-NMDA 30
Downloaded from http://nar.oxfordjournals.org/ at Library of Research Reactor Institute, Kyoto University on July 28, 2013
Figure 3. Identication of the trans-acting molecules affecting nucleocytoplasmic distribution of CPEB3. (A) The scheme of virus-based shRNA
knockdown screening to identify candidate karyopherins (see Supplementary Table S1 for all shRNA information). The neurons infected with
lentiviruses expressing 174 shRNAs were stimulated with or without 20 mM NMDA and detected with MAP2 and CPEB3 antibodies and DAPI
nuclear staining. N: nucleus; C: cytoplasm. Representative images from the screening are shown in (B). (C) The average cell number and (D) CPEB3
N/C ratio in each dataset (calculated from 174 shRNAs data) are displayed as bar graphs. (E) The cell numbers in each shRNA-infected well from
duplicate datasets were averaged and plotted against the mean CPEB3 N/C ratio. (F) The mean CPEB3 N/C ratios obtained from 174
shRNA-targeted and NMDA-treated neurons are arranged in an increasing order (red line) and the ratios of their untreated counterparts are
plotted in blue. The average CPEB3 N/C ratios from Ctrl- and NMDA-treated datasets are 1.12 0.10 and 1.44 0.15 (mean SD), respectively.
(G) The shRNAs, which affect the CPEB3 N/C ratio beyond 95% condence interval (mean 1.96 SD) in NMDA-stimulated neurons are listed. All
error bars denote SD.
Downloaded from http://nar.oxfordjournals.org/ at Library of Research Reactor Institute, Kyoto University on July 28, 2013
proteins. Nonetheless, the nuclear CPEB3 signal was signicantly elevated in these two shRNA knockdown
neurons. That could be caused by secondary or RNAi
off-target effects. Thus, if IPO5 is the trans-acting factor
directly facilitating the nuclear translocation of CPEB3, it
should bind to CPEB3 through the identied NLS in the
RRM1 (Figure 2). To assess CPEB3IPO5 interaction,
HeLa cells expressing EGFP-IPO5 along with or
without various myc-tagged CPEB3 mutants (Figure 5A)
were either pulled down with GFP or myc antibody and
immunodetected with GFP and myc antibodies. Co-IPs
depict that IPO5 interacts with CPEB3 depending on
RRM1, because wt, C and mut6, but not N and mut7,
bind to IPO5 (Figure 5B). To map which region in IPO5 is
essential for the association with CPEB3, HeLa cells expressing myc-CPEB3 and various EGFP-tagged truncated
IPO5 mutants (Figure 5C) were precipitated with myc or
GFP antibody and immunoblotted with GFP and myc
antibodies. The cargo-binding domain (C1, a.a. 411
1115) of IPO5 is important for binding to CPEB3
(Figure 5D).
Downloaded from http://nar.oxfordjournals.org/ at Library of Research Reactor Institute, Kyoto University on July 28, 2013
Figure 4. NMDA-induced nuclear accumulation of CPEB3 and IPO5 is impaired in IPO5 knockdown neurons. (A) Neurons infected with
lentiviruses expressing without (siCtrl) or with IPO5 shRNAs, #1, TRCN00000101932 and #2, TRCN00000101931) were analysed by western
blotting with IPO5 and actin antibodies. (B) The siCtrl and siIPO5 (#2 clone) neurons were treated with 20 mM NMDA for the indicated time
courses and then immunostained with CPEB3, IPO5 and MAP2 antibodies and DAPI staining. The secondary antibodies used for CPEB3, IPO5 and
MAP2 are conjugated with Alexa Fluor 546, Alexa Fluor 633 and FITC, respectively. The CPEB3 and IPO5 images are pseudo-coloured in green
and red, respectively (see Supplementary Figure S2 for more images). A line drawn across the cell body was analysed for the uorescence intensities
of CPEB3, IPO5, MAP2 and DAPI. The nucleocytoplasmic border appears at the crossover point of MAP2 and DAPI signal lines. Scale: 20 mm
(C) The 7.2 mm-long distance of cytoplasmic (C) and nuclear (N) CPEB3 signal in siCtrl (red line) and siIPO5 (green line) neurons treated
with NMDA is plotted against distance. Error bars indicate SEM. The blue and yellow lines are the average DAPI (nucleus) and MAP2 (cytoplasm) signals. (D) For each neuron, the sum of 7.2 mm-long CPEB3 signal in the nucleus divided by that in the cytoplasm yields the N/C ratio in the
dot plot. The quantied N/C ratio (mean SEM) and the number of analysed neurons are listed at the bottom. (E and F) The IPO5 signal was
analysed in the same way.
myc-
RRM1
RRM2
zif
CPEB3
binding to
IPO5
wt (1-684)
N (1-427)
C (426-684)
mut6 (318-425)
mut7 (427-533)
+
+
+
-
IgG H.C.
myc
myc
EGFPIPO5
input
input
IP
IP
RanGTP
NPC
cargo
acidic loop
IPO5
EGFP-
wt (1-1115)
N (1-411)
C1 (411-1115)
C2 (833-1115)
binding to
CPEB3
+
+
-
mycCPEB3
EGFP
EGFP
mycCPEB3
input
IP
IP
Figure 5. CPEB3 binds to the C-terminus of IPO5 through its RRM1. (A) The domain organization of CPEB3 and various truncated mutants.
(B) Co-IP assay. HeLa cells were co-transfected with EGFP-IPO5 plasmid along with various myc-tagged CPEB3 constructs. The cell lysates were
immunoprecipitated with GFP or myc antibody, and immunoblotted with myc and GFP antibodies. IP, immunoprecipitation; IB, immunoblotting.
(C) The domain organization of IPO5 and various deleted mutants. NPC, nuclear pore complex. (D) HeLa cells expressing myc-CPEB3 along with
various EGFP-tagged wt and mutant IPO5 proteins were pulled down by myc or GFP antibody. The precipitated substances were immunodetected
with myc and GFP antibodies.
Downloaded from http://nar.oxfordjournals.org/ at Library of Research Reactor Institute, Kyoto University on July 28, 2013
EGFPIPO5
DNA transfection
(EGFP-CPEB3 flag-IPO5)
virus infection
(siCtrl or siIPO5)
DIV10
DIV12
DIV14
DIV11
puromycin selection
time-lapse
recording
6 min
9 min
12 min
15 min
18 min
6 min
9 min
12 min
15 min
18 min
21 min
24 min
27 min
30 min
33 min
36 min
vs
**
*
*
vs
P< 0.05
**
P< 0.01
0
-30
-15
15
30
45
60
75 min
Figure 6. NMDAR signaling accelerates the nuclear import of CPEB3. (A) The scheme for live imaging of EGFP-CPEB3 import. (B) The siCtrl
and siIPO5 neurons expressing EGFP-CPEB3 at DIV 14 were recorded for 30 min prior to stimulation with NMDA. Some time-lapse images are
shown. Scale: 20 mm. The signal in the nuclear region circled in yellow was measured and (C) plotted against the time of recording with the
uorescence intensity at the middle of baseline (15 min) arbitrarily set to one. The nuclear import dynamics of EGFP-CPEB3 under various
conditions are shown in different colours. Error bars indicate SEM. The time windows showing statistical difference between groups are denoted
(Students t-test).
Downloaded from http://nar.oxfordjournals.org/ at Library of Research Reactor Institute, Kyoto University on July 28, 2013
input
NMDA -
IP (IPO5 IgG)
IP (CPEB3 IgG)
-
5 10 15 30 45
5 10 15 30 45
5 10 15 30 45
input
IPO5
1 1.55 2.03 2.99 2.51 2.53
IPO5/CPEB3 1 1.58 2.25 3.10 3.11 4.15
15 30
Ran
1 1.17 1.08 0.98
1 0.80 0.73
Exp.
2
Ran
1 0.90 1.0 0.92
Ran
Not detectable
IP (RanGTP )
-
15 30
Exp.
1
CPEB3
1 0.98 0.90 0.96 0.81 0.61
NMDA
1 0.96 0.84
myc-CPEB3
EGFP-IPO5
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
myc-CPEB3
EGFP-IPO5
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
myc-CPEB3
myc-CPEB3
1 0.44 0.32
3.39 2.84 1
CPEB3/IPO5
EGFP-IPO5
EGFP-IPO5
1 0.53 1.07
2.02 1 2.21
IPO5/Ran
IPO5/CPEB3
flag
flag
1 1.07 0.98
input
IP flag
3 NMDA
-
25
Ran/CPEB3
input
IP myc
NMDA
50 75
1 0.73 0.33
2.99 2.07 1
25 50 75
NMDAR
RanBP1
RanBP1
RanBP1
IPO5
-tubulin
1
IPO5
RanBP1
RanGTP
RanGTP
RanGAP
IPO5
CPEB3
NMDA
RanGDP
IPO5
lamin B
1
0.58 1 0.62 1
1 0.87
2.16
1 1.06
CPEB3 RanGDP
CPEB3
IPO5
-tubulin
IPO5
CPEB3
RCC1
LMB
1 1.03 1 0.81
Ran
1
CPEB3
RanGDP
Sy38
CRM1
RanGTP
CPEB3
-actin
1 0.97 1 0.95 1 0.67
Cytoplasm
Nucleus
Figure 7. NMDAR signaling enhances CPEB3IPO5 interaction through Ran-related changes. (A) Neurons stimulated with 3 min of NMDA and
then incubated for the denoted time were used for IP with CPEB3 and IPO5 IgGs, followed by immunodetection with IPO5, CPEB3 and Ran
antibodies. The intensities of immunodetected signals analysed by the ImageJ software are displayed as relative ratios at the bottoms of blots. The
ratios of the co-precipitated target versus the immunoprecipitated protein (IPO5/CPEB3 or CPEB3/IPO5) are shown in red. (B) The cytoplasmic
fraction isolated from neurons treated with NMDA was precipitated with the RanGTP antibody and immunoblotted with Ran antibody.
(C and D) HeLa cells expressing myc-CPEB3, EGFP-IPO5 along with Ran-wt, T24N or Q69L mutant were pulled down with (C) ag or (D)
myc antibodies. The precipitated substances were probed with GFP, myc and ag antibodies. (E) Neurons stimulated with a pulse of NMDA or
NMDA for the indicated times were harvested for western blotting using RanBP1 and tubulin antibodies. (F) The nuclear and cytosol lysates
fractionated from neurons treated with NMDA for 30 min were used for immunoblotting. (G) Schematic model of NMDA-induced nuclear import
of CPEB3. NMDAR signaling increases RanBP1 expression, combined with RanGAP to stimulate Rans GTPase activity. Consequently, the
IPO5-RanGDP complex can bind to CPEB3 and deliver CPEB3 to the nucleus. After nuclear import, a high RanGTP concentration and RCC1
in the nucleus triggers the release of CPEB3 from the ternary complex because RanGTP impairs the interaction between IPO5 and CPEB3. The
nuclear export of CPEB3 is mediated by CRM1.
Downloaded from http://nar.oxfordjournals.org/ at Library of Research Reactor Institute, Kyoto University on July 28, 2013
DISCUSSION
We have identied the molecular mechanism underlying
the NMDA-induced nuclear import of CPEB3. IPO5, also
known as RanBP5, importin b3 and karyopherin b3
(KPNB3), is the key trans-acting factor to facilitate the
nuclear translocation of CPEB3 in NMDA-treated
neurons. Because CPEB3 plays a cytoplasmic role in
translation and a nuclear role in transcription, the
activity-induced change in CPEB3 localization may partition CPEB3s function in translation and transcription.
Because CPEB3 is localized in the synaptodendritic
region (17), CPEB3 may also be transported from
NMDAR-activated synapses into the nucleus to engage
and facilitate the dendritic transport of its target RNAs.
Downloaded from http://nar.oxfordjournals.org/ at Library of Research Reactor Institute, Kyoto University on July 28, 2013
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Table 1, Supplementary Figures 15 and
Supplementary Data.
ACKNOWLEDGEMENTS
The authors thank Joel Richter for polyclonal
CPEB3 antibody, Yi-Ping Hsueh for lamin B antibody,
Chiaho Shih for CRM1 antibody, Dirk Gorlich
for the pQE30-IPO5 plasmid and Mien-Chie Hung
for pcDNA3.1-ag-Ran and pcDNA3.1-ag-RanQ69L
plasmids. They appreciate Thomas Nieland and David
Root for helping to establish the shRNA screening
protocol and Sue-Ping Lees assistance with the confocal
image analysis. They thank the National RNAi Core
Facility in Academia Sinica for the shRNA viruses and
clones.
FUNDING
National Science Council [NSC 99-2311-B-001-020-MY3];
National Health Research Institute [NHRI-EX1019814NI]; Academia Sinica [AS-100-TP-B09] in Taiwan.
Downloaded from http://nar.oxfordjournals.org/ at Library of Research Reactor Institute, Kyoto University on July 28, 2013
Downloaded from http://nar.oxfordjournals.org/ at Library of Research Reactor Institute, Kyoto University on July 28, 2013
SUPPLEMENTARY FIGURES
cell #
Series1
-puro
1200
Series2
+puro,
Series3
+puro,
NMDA
Ctrl
900
600
300
0
10
15
20
viral titer (x103/ml)
25
Supplementary Figure S1. A positive correlation between the survived neuron number and the
viral titer. The cell numbers in 174 shRNA-infected wells with or without puromycin selection
and/ or NMDA treatment are plotted against the titers of 174 lentiviruses.
IPO5
DAPI
MAP2
+ NMDA, 15 min
+ NMDA, 30 min
+ NMDA, 45 min
siIPO5
siCtrl
siIPO5
siCtrl
siIPO5
siCtrl
siIPO5
- NMDA
siCtrl
CPEB3
Supplementary Figure S2. Distribution of CPEB3 and IPO5 in neurons. The siCtrl and siIPO5 neurons
were treated with 20 mM NMDA for the indicated time courses and then immunostained with CPEB3,
IPO5, and MAP2 antibodies and DAPI staining. The secondary antibodies used for CPEB3, IPO5 and
MAP2 are conjugated with Alexa Fluor 546, Alexa Fluor 633, and FITC, respectively. The CPEB3 and
IPO5 images are pseudo-colored in green and red, respectively. Scale: 20 mm.
+ LMB
35
40
45
10
15
20
25
30
50
55
60
65
70
Supplementary Figure S3. Photoconversion of Dendra2-CPEB3 in Neuro-2a and neurons. (A) Neuro-2a
cells and (B) neurons expressing Dendra2-CPEB3 were photoactivated with a 405 nm laser and then
recorded for both converted (red) and non-converted (green) Dendra2 signals.
Neuro-2a
kDa
EGFPCPEB3
EGFPIPO5
250
130
100
EGFPCPEB3
EGFPIPO5
EGFP-IPO5
EGFP-IPO5
EGFP-CPEB3
IPO5
70
a EGFP
a IPO5
Supplementary Figure S4. Expression of EGFP-tagged CPEB3 and IPO5 in Neuro-2a cells. Neuro-2a
cells expressing EGFP-CPEB3 and EGFP-IPO5 were immunoblotted with GFP and IPO5 antibodies.
input
NMDA
10
15
IP (aCPEB3 IgG)
30 45
10 15
30
45
CRM1
1
CRM1/CPEB3 1
CPEB3
Supplementary Figure S5. NMDAR signaling slightly reduces CPEB3-CRM1 interaction. Neurons
stimulated with 3 min of NMDA and then incubated for the denoted time were used for
immunoprecipitation with CPEB3 IgG, followed by immunodetection with CRM1 and CPEB3. The ratios of
CRM1 versus CPEB3 signals are shown in red.